AMIODARONE IN THE MANAGEMENT OF CARDIAC-ARRHYTHMIAS - CURRENT CONCEPTS

被引：15

作者：

ROTMENSCH, HH

BELHASSEN, B

机构：

[1] TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL

[2] ICHILOV HOSP,TEL AVIV MED CTR,DEPT CARDIOL,CARDIAC ELECTROPHYSIOL LAB,IL-64239 TEL AVIV,ISRAEL

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1988年 / 72卷 / 02期

关键词：

D O I：

10.1016/S0025-7125(16)30773-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：321 / 358

页数：38

共 298 条

[1] AMIODARONE AND ITS DESETHYL METABOLITE - TISSUE DISTRIBUTION AND MORPHOLOGIC CHANGES DURING LONG-TERM THERAPY
ADAMS, PC
HOLT, DW
STOREY, GCA
MORLEY, AR
CALLAGHAN, J
CAMPBELL, RWF
[J]. CIRCULATION, 1985, 72 (05) : 1064 - 1075
[2] ADAMS PC, 1985, LANCET, V1, P341
[3] EFFECTS OF AMIODARONE ON SUPRAVENTRICULAR TACHYCARDIA INVOLVING BYPASS TRACTS
ALBONI, P
SHANTHA, N
PIRANI, R
BAGGIONI, F
SCARFO, S
TOMASI, AM
MASONI, A
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (01) : 93 - 98
[4] CUTANEOUS HYPERPIGMENTATION INDUCED BY AMIODARONE HYDROCHLORIDE
ALINOVI, A
REVERBERI, C
MELISSARI, M
GABRIELLI, M
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 12 (03) : 563 - 566
[5] MECHANISM OF WARFARIN POTENTIATION BY AMIODARONE - DOSE-DEPENDENT AND CONCENTRATION-DEPENDENT INHIBITION OF WARFARIN ELIMINATION
ALMOG, S
SHAFRAN, N
HALKIN, H
WEISS, P
FARFEL, Z
MARTINOWITZ, U
BANK, H
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (03) : 257 - 261
[6] CLINICAL AND CHEMICAL ASSESSMENT OF THYROID-FUNCTION DURING THERAPY WITH AMIODARONE
AMICO, JA
RICHARDSON, V
ALPERT, B
KLEIN, I
[J]. ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (03) : 487 - 490
[7] ANASTASIOUNANA M, 1982, INT J CLIN PHARM TH, V20, P524
[8] ANASTASIOUNANA MI, 1985, CIRCULATION S3, V72, P111
[9] DISABLING NEUROLOGICAL COMPLICATIONS OF AMIODARONE
ANDERSON, NE
LYNCH, NM
OBRIEN, KP
[J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1985, 15 (03): : 300 - 304
[10] PHARMACOKINETICS OF AMIODARONE AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
ANDREASEN, F
AGERBAEK, H
BJERREGAARD, P
GOTZSCHE, H
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (04) : 293 - 299

← 1 2 3 4 5 6 7 8 9 10 →